CONMED (NYSE:CNMD): Q1 Non-GAAP EPS of $0.63 beats by $0.19; GAAP EPS of $0.31 beats by $0.04.Revenue of $232.67M (+8.7% Y/Y) beats by $15.79M.Press Release
Pune, India, March 23, 2021 (GLOBE NEWSWIRE) -- The Global Anterior Cruciate Ligament (ACL) Reconstruction Market without the COVID-19 impact was valued at USD 4,257.38 million...
CONMED Corporation (NYSE:CNMD) is well poised for growth backed by broad product portfolio, strong international sales and solid gain from core units — Orthopedic Surgery...
The coronavirus crisis continues to rattle global markets. Adding to the angst, the WHO declared the disease to be a pandemic yesterday. Notably, the S&P 500 index fell 4.9%...
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.